Cite

HARVARD Citation

    Lee, K. et al. (2017). Metformin is associated with fewer major adverse cardiac events among patients with a new diagnosis of type 2 diabetes mellitus. Medicine. 96 (28), p. . [Online]. 
  
Back to record